This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.
Background
How patients with osteoarthritis of the knee felt and functioned twelve months after a single ultrasound-guided injection of their own fat tissue (MFAT) into the joint — using their own ratings of pain, function, and quality of life.
Rationale
The decisions that matter most in arthritis care — whether you can climb stairs, sleep through the night, walk to the shops — are best measured by asking patients themselves, rather than relying solely on x-rays. We wanted to know whether MFAT translates into improvements in the things patients actually care about.
Results
110 knees were followed for a year. Pain scores, function scores, and quality-of-life scores all improved significantly — pain levels roughly halved on the patients’ own scale. No serious side effects were reported during or after the procedure. The benefit was seen across all grades of arthritis severity.
Implications
For patients with knee arthritis, a single MFAT injection may meaningfully reduce pain and support better day-to-day function for at least a year. The study is observational and there was no comparison group, so we cannot rule out other factors contributing to the improvement — but the size of the change in patient-reported scores is encouraging and consistent with our other work.
Source: Heidari N, Noorani A, Slevin M, Cullen A, Stark L, Olgiati S, et al.. Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve Months. Stem Cells International 2020;2020:8881405. doi:10.1155/2020/8881405
Read full open-access paper (PDF) → Read original on PubMed → ← Back to research library